Different antihyperglycaemic drug effects on glycaemic variability in Type 2 diabetic patients

Optimizing treatments for type 2 diabetes mellitus (T2DM) remains an urgent issue. In addition to T2DM treatment strategies, such as glycaemic goals (glucose and glycated haemoglobin ? HbА1c) among different patient populations, the influence of glycaemic variability (GV) on the prognosis of patient...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Alina Babenko, Elena Ivanovna Krasilnikova, Nikolay Pavlovich Likhonosov, Anna Pavlovna Likhonosova, Elena Nikolaevna Grineva
Format: article
Langue:EN
RU
Publié: Endocrinology Research Centre 2014
Sujets:
Accès en ligne:https://doaj.org/article/eff73a7fd76a4619b9da53893fae77f0
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!